N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes

Fibroproliferative diseases are responsible for 45% of deaths in the developed world. Curing organ fibrosis is essential for fibroproliferative diseases. Diabetic nephropathy is a common fibroproliferative disease of the kidney and is associated with multiorgan dysfunction. However, therapy to comba...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanasaki, Keizo, Nagai, Takako, Nitta, Kyoko, Kitada, Munehiro, Koya, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995071/
https://www.ncbi.nlm.nih.gov/pubmed/24782774
http://dx.doi.org/10.3389/fphar.2014.00070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995071/
https://www.ncbi.nlm.nih.gov/pubmed/24782774
http://dx.doi.org/10.3389/fphar.2014.00070

Ejemplares similares